Literature DB >> 3779741

Usefulness of the phenomenon of histofluorescence in the identification of early myocardial necrosis.

S P Allwork, H H Bentall.   

Abstract

To evaluate the histological phenomenon of fluorescence of necrotic myocardium in ultraviolet light a prospective study of fatal myocardial infarction with accurate clinical and biochemical correlation was made. To test the morphological characteristics and specificity of the technique experimental infarctions were induced surgically in sheep and pigs and acute ischaemia and infarction induced by catheter in intact dogs. Fluorescence was visible within five minutes of the injury in routinely stained sections and persisted for as long as cellular debris was identifiable. It was independent of autolysis, optimal fixation, prolonged storage, and special stains. Although the fluorescence was associated with hypereosinophilia in stained sections, necrotic myocardium also fluoresced in unstained ones, demonstrating primary or autofluorescence. Fluorescence microscopy is a useful adjunct to the histological identification of early myocardial necrosis and of scattered or focal necrosis especially in the absence of myocardial infarction.

Entities:  

Mesh:

Year:  1986        PMID: 3779741     DOI: 10.1093/cvr/20.6.451

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  2 in total

1.  Dead or alive? Autofluorescence distinguishes heat-fixed from viable cells.

Authors:  Leah Hennings; Yihong Kaufmann; Robert Griffin; Eric Siegel; Petr Novak; Peter Corry; Eduardo G Moros; Gal Shafirstein
Journal:  Int J Hyperthermia       Date:  2009-08       Impact factor: 3.914

2.  Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression.

Authors:  Nikol Snoeren; Joost Huiskens; Arjen M Rijken; Richard van Hillegersberg; Arian R van Erkel; Gerrit D Slooter; Joost M Klaase; Petrousjka M van den Tol; Fibo J W Ten Kate; Maarten C Jansen; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2011-05-18       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.